Search Result "alirocumab"


Letter to the Editor

Alirocumab in Post ACS Patients - Saving Lives at a Premium

Journal: Current Cardiology Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 3-4
Author(s): Melvin George,Luxitaa Goenka

Systematic Review Article

Efficacy and Safety of Alirocumab and Evolocumab as ProproteinConvertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in FamilialHypercholesterolemia: A Systematic Review and Meta-Analysis

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 223-241
Author(s): Ali Akbar Soleimani

Review Article

Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3647-3653
Author(s): Vasilios Papademetriou,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Konstantinos Koutsampasopoulos,Kiriakos Dimitriadis,Kostas Tsioufis

Cross-Sectional Study

Analysis of Adherence to anti-PCSK9 Antibody Therapy among Patients from Italy

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 23 Issue: 2 Year: 2023 Page: 111-121
Author(s):

Review Article

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1484-1494
Author(s): Joel Schmitz,Ioanna Gouni-Berthold

Review Article

PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni

Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

Review Article

Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance

Journal: Current Medicinal Chemistry
Volume: 25 Issue: 13 Year: 2018 Page: 1538-1548
Author(s): Julia Schreml,Ioanna Gouni-Berthold

Review Article

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1403-1416
Author(s): Luca Liberale,Fabrizio Montecucco,Giovanni G. Camici,Franco Dallegri,Alessandra Vecchie,Federico Carbone,Aldo Bonaventura

Review Article

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3638-3646
Author(s): Vasilios G. Athyros,Niki Katsiki,Aikaterini Dimakopoulou,Dimitrios Patoulias,Sofia Alataki,Michael Doumas

Previous   Next

Go To   Results 1 - 1 of 78

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy